Regulatory Rumblings Archive

June 2019

ANA Joins Opposition to HHS Prescription Drug Price Disclosure Rule

Posted: Jun 14, 2019 3:45pm ET

ANA has joined with Merck, Eli Lilly, and Amgen to bring a lawsuit to enjoin a HHS rule concerning prescription drugs that would otherwise blow significant holes in advertisers First Amendment protections.